O. S. Weislow

New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity

O. S. Weislow, Rebecca Kiser, Donald L. Fine et al. · JNCI Journal of the National Cancer Institute · 1989 · 689 citations

Molecular Pharmacology, High-flux Screening, New Soluble-formazan Assay +13

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

John R. Mascola, S W Snyder, O. S. Weislow et al. · The Journal of Infectious Diseases · 1996 · 433 citations

AIDS-Antiviral Sulfolipids From Cyanobacteria (Blue-Green Algae)

Kirk R. Gustafson, John H. Cardellina, Richard W. Fuller et al. · JNCI Journal of the National Cancer Institute · 1989 · 299 citations

Tetrazolium Assay, Medicinal Chemistry, Bioorganic Chemistry +13

Potent and selective activity of a new carbocyclic nucleoside analog (Carbovir: NSC 614846) against human immunodeficiency virus In vitro

Robert Vince, Hua Mei, Jay Brownell et al. · Biochemical and Biophysical Research Communications · 1988 · 231 citations · Full text

Medicinal Chemistry, Medicine, Immunology +12

Antiviral Effect and Ex Vivo CD4 ⁺ T Cell Proliferation in HIV-Positive Patients as a Result of CD28 Costimulation

Bruce L. Levine, Joseph D. Mosca, James L. Riley et al. · Science · 1996 · 220 citations